Thomas explains the origins of her interest in children’s literature and young adult fiction, as well as what to expect from her new book, ‘The Dark Fantastic.’
Ebony Elizabeth Thomas, associate professor of literacy, culture, and international education in the Graduate School of Education.
Welcome to the “office hours” of Ebony Elizabeth Thomas, associate professor of literacy, culture, and international education in the Graduate School of Education.
Here, in the latest episode of the “Office Hours” podcast series produced by Penn Today, which explores the minds of the University’s academic talents in a more unbuttoned and freewheeling setting outside of the lecture hall, Thomas discusses growing up with limited children’s literature options, where young adult and children’s lit is going today, why she still hasn’t watched “The Wire,” and what she thinks is an overrated virtue.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
